Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Company announcement – No. 29 / 2020 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, May 26, 2020 – Zealand Pharma A/S (“Zealand”) (NASDAQ:...
-
Company Announcement – No. 28 / 2020 Zealand Pharma announces FDA acceptance of New Drug Application for the dasiglucagon HypoPal® rescue pen for treatment of severe hypoglycemia The dasiglucagon...
-
Company announcement – No. 27 / 2020 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...
-
Zealand Pharma files New Drug Application with U.S. FDA for dasiglucagon HypoPal® rescue pen, secures DKK 137 million in additional investment, and accelerates readiness of U.S. commercial operations ...
-
Company announcement – No. 25 / 2020 Total number of shares and voting rights in Zealand Pharma at April 30, 2020 Copenhagen, April 30, 2020 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a...
-
Company announcement – No. 24 / 2020 Zealand Pharma announces amendments to its Articles of Association following the granting of warrants Copenhagen, April 29, 2020 – Zealand Pharma A/S (Nasdaq:...
-
Company announcement – No. 23 / 2020 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...
-
Company announcement – No. 22 / 2020 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...
-
Press Release – No. 05 / 2020 Zealand Pharma hosts conference call on May 14 at 4 pm CEST (10 am EDT) to present first quarter results for 2020 Copenhagen, April 20, 2020 – Zealand Pharma A/S...
-
Company announcement – No. 21 / 2020 Zealand Pharma grants warrants and restricted stock units under the employee warrant program and management long-term incentive program Copenhagen, April 15,...